Doximity, Inc. (DOCS)

US — Healthcare Sector
Peers: TDOC  SDGR  TXG  PGNY  CERT  HQY  RCM  ACCD  VEEV  AMWL  GEHC  DH 

Automate Your Wheel Strategy on DOCS

With Tiblio's Option Bot, you can configure your own wheel strategy including DOCS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol DOCS
  • Rev/Share 3.0282
  • Book/Share 5.7476
  • PB 9.0369
  • Debt/Equity 0.0114
  • CurrentRatio 6.9669
  • ROIC 0.1737

 

  • MktCap 9753807354.0
  • FreeCF/Share 1.4241
  • PFCF 36.3613
  • PE 43.8359
  • Debt/Assets 0.0098
  • DivYield 0
  • ROE 0.2238

 

  • Rating A-
  • Score 4
  • Recommendation Buy
  • P/E Score 1
  • DCF Score 4
  • P/B Score 1
  • D/E Score 4

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade DOCS Leerink Partners Market Perform Outperform $60 $90 Feb. 7, 2025
Upgrade DOCS Piper Sandler Neutral Overweight $31 $78 Feb. 7, 2025
Initiation DOCS Stephens -- Equal Weight -- $55 Dec. 20, 2024
Initiation DOCS Mizuho -- Neutral -- $55 Dec. 4, 2024
Upgrade DOCS Barclays Equal Weight Overweight $35 $52 Oct. 15, 2024

News

Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
DOCS
Published: May 21, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors.

Read More
image for news Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
Doximity Stock Plunges Despite Q4 Earnings & Sales Beat, Margins Up
DOCS
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Neutral

DOCS reports robust growth in unique active users and sales of workflow tools, driving the top and bottom lines. First-quarter fiscal 2026 sales outlook below estimates.

Read More
image for news Doximity Stock Plunges Despite Q4 Earnings & Sales Beat, Margins Up
DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
DOCS
Published: May 15, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (NYSE: DOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022, to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company.

Read More
image for news DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript
DOCS
Published: May 15, 2025 by: Seeking Alpha
Sentiment: Neutral

Doximity, Inc. (NYSE:DOCS ) Q4 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Perry Gold - Head of IR Jeff Tangney - Co-Founder and CEO Anna Bryson - CFO Nate Gross - Co-Founder and CSO Conference Call Participants Brian Peterson - Raymond James Michael Cherny - Leerink Partners Elizabeth Anderson - Evercore ISI Ryan MacDonald - Needham Jared Haase - William Blair Allen Lutz - Bank of America Scott Schoenhaus - KeyBanc Ann Samuel - JPMorgan Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler Steven Veliquette - Mizuho Securities Jeff Garro - Stephens David …

Read More
image for news Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm
DOCS
Published: May 15, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders.

Read More
image for news Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm
Doximity Q4 Earnings Likely to Reflect Strong Product Momentum
DOCS
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive

Doximity's Q4 performance likely witnessed strong product-driven gains from new modules and integrated programs, though early revenue pull-forward might have tempered sequential growth.

Read More
image for news Doximity Q4 Earnings Likely to Reflect Strong Product Momentum
Doximity: Strong Fundamentals And Pharma Tailwinds Meet An Overpriced Valuation
DOCS
Published: May 01, 2025 by: Seeking Alpha
Sentiment: Neutral

Doximity is experiencing strong user engagement growth, driven by demand from medical prescribers and pharmaceutical marketers. Pharma marketing, Doximity's largest opportunity, is fueling sustained momentum alongside the early success of new platform tools. Integrated features like the client portal drive network effects and boost customer stickiness through real-time marketing insights.

Read More
image for news Doximity: Strong Fundamentals And Pharma Tailwinds Meet An Overpriced Valuation
5 Momentum Stocks to Buy for April Despite a Disappointing March
APP, DOCS, MRVL, RDDT, VEEV
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive

Five stocks have strong momentum for April. These are: APP, MRVL, DOCS, RDDT, VEEV.

Read More
image for news 5 Momentum Stocks to Buy for April Despite a Disappointing March
3 Medical Services Industry Stocks to Buy as AI Fuels Growth
COR, DOCS, MD
Published: March 27, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most.

Read More
image for news 3 Medical Services Industry Stocks to Buy as AI Fuels Growth
Buy These 5 Top-Ranked Stocks to Play Likely Earnings Beat
ATGE, BMRN, DOCS, IRDM, LTH
Published: March 12, 2025 by: Zacks Investment Research
Sentiment: Positive

Top-ranked stocks Doximity (DOCS), Life Time Group Holdings (LTH), Adtalem Global Education (ATGE), BioMarin Pharmaceutical (BMRN) and Iridium Communications (IRDM) are likely to beat on the bottom line in their upcoming releases.

Read More
image for news Buy These 5 Top-Ranked Stocks to Play Likely Earnings Beat
Is Doximity (DOCS) a Solid Growth Stock? 3 Reasons to Think "Yes"
DOCS
Published: February 28, 2025 by: Zacks Investment Research
Sentiment: Positive

Doximity (DOCS) possesses solid growth attributes, which could help it handily outperform the market.

Read More
image for news Is Doximity (DOCS) a Solid Growth Stock? 3 Reasons to Think "Yes"
5 Top-Ranked Stocks Poised for an Earnings Beat
DOCS, FTNT, GRMN, LYFT, THC
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive

Top-ranked stocks Tenet Healthcare (THC), Fortinet (FTNT), Lyft (LYFT), Garmin (GRMN) and Doximity (DOCS) are likely to beat on the bottom line in their upcoming releases.

Read More
image for news 5 Top-Ranked Stocks Poised for an Earnings Beat
Doximity: Rating Downgrade As Near-Term Upside Is Priced In
DOCS
Published: February 14, 2025 by: Seeking Alpha
Sentiment: Positive

I downgraded Doximity from buy to hold due to expected growth slowdown and current high valuation at 40.5x forward EBITDA. DOCS reported strong Q3 performance with $168.6 million revenue, 25% y/y growth, and 93.3% gross margin, driven by high pharma client demand. New ad products grew over 100% y/y, now contributing >20% of pharma revenue, showing strong underlying demand and expanding advertiser engagement.

Read More
image for news Doximity: Rating Downgrade As Near-Term Upside Is Priced In
Doximity Momentum, Big Money Support Stays Strong
DOCS
Published: February 14, 2025 by: FXEmpire
Sentiment: Positive

Shares of Doximity, Inc. (DOCS) jump on business growth, investor inflows.

Read More
image for news Doximity Momentum, Big Money Support Stays Strong
Doximity (DOCS) is an Incredible Growth Stock: 3 Reasons Why
DOCS
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive

Doximity (DOCS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Read More
image for news Doximity (DOCS) is an Incredible Growth Stock: 3 Reasons Why
Why Doximity (DOCS) Might be Well Poised for a Surge
DOCS
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive

Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Read More
image for news Why Doximity (DOCS) Might be Well Poised for a Surge
Doximity (DOCS) is a Great Momentum Stock: Should You Buy?
DOCS
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive

Does Doximity (DOCS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Read More
image for news Doximity (DOCS) is a Great Momentum Stock: Should You Buy?

About Doximity, Inc. (DOCS)

  • IPO Date 2021-06-24
  • Website https://www.doximity.com
  • Industry Medical - Healthcare Information Services
  • CEO Mr. Jeffrey A. Tangney
  • Employees 827

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.